"NCIP seeks nominations for the Samuel L. Katz, M.D. Excellence in Immunization Award; submit by Oct. 31, 2025."
Press Releases
Dear Local Health Departments,On Wednesday, Aug. 27, 2025, FDA approved the updated 2025-2026 COVID-19 vaccines and rescinded Emergency Use Authorizations (EUA) for previously authorized COVID-19 vaccines.
Dear Providers,On Wednesday, Aug. 27, 2025, FDA approved the updated 2025-2026 COVID-19 vaccines and rescinded Emergency Use Authorizations (EUA) for previously authorized COVID-19 vaccines.As a result of the 2024–2025 COVID-19 EUA rescissions, providers are required to stop using those vaccine products or presentations immediately. Any COVID-19 vaccine products that were authorized under an EUA should be removed from storage, removed in NCIR as wasted, and returned per routine NCIP vaccine wastage guidelines.
"NCIP releases a 30-min Childhood Vaccine Education Webinar with strategies for addressing vaccine hesitancy in families."
Dear Local Health Department Partner,As a follow-up to our August 6th communication, we want to remind you that NCIP received additional 317 VFA funding to support MMR vaccine availability for Local Health Departments.These supplemental doses are available for all uninsured and underinsured unvaccinated adults who are susceptible and lack documentation of prior MMR vaccination.
This memo is to inform North Carolina Immunization Program (NCIP) providers of the availability of influenza vaccine and the ordering process for the 2025-2026 respiratory season. Please take time to carefully review this memo in full.
"NC COVID-19 2024–25 vaccine orders: Pfizer by 8/7/25, Moderna by 8/24/25; use all doses before expiration."
"NCIP announces additional 317 funds for LHDs to provide MMR vaccine to uninsured and underinsured adults until September or while supplies last."
The purpose of this email is to remind VFC-enrolled providers that the monoclonal antibody product nirsevimab (trade name Beyfortus® manufactured by Sanofi) will be available for ordering on Friday, August 1, 2025.
Download the RSV Vaccine Available for Ordering MemoThe purpose of this memo is to provide VFC- enrolled providers with information on ordering timelines and administration start dates for the maternal RSV vaccine (ABRYSVO®) and the monoclonal antibody nirsevimab (Beyfortus®) for the upcoming season.